Contracts & Pricing April 11, 2022 Best Price and Copay Challenges: Frequently Asked Questions 11 Minute Read Common manufacturer concerns on best price calculations, copay accumulators and maximizers, and 340B management as the effective date for the CMS Final Rule approaches.
Contracts & Pricing March 28, 2022 Medicare Part B Sequestration Update 3 Minute Read Regulatory Market Update Updates for Pharma Manufacturers As always, if you have questions on any of the content found in this or previous market updates, please reach out to...
Launch Readiness March 24, 2022 Best Practices: Achieving Your Pre-Launch Sales Forecasts 6 Minute Read Market access leaders from DBV Technologies, Karyopharm Therapeutics, and Sesen Bio discuss critical factors in a successful launch and ways to achieve pre-launch forecasts.
ICyte Platform March 7, 2022 Unifying IntegriChain’s Services & Support: Customer Support and Value Realization 4 Minute Read In his second unification-focused blog, President and COO Josh Halpern discusses IntegriChain's investment in customer support to better augment the value for customers and end-users.
Market Access Blogs February 28, 2022 Overcoming Drug Commercialization Challenges in Rare Disease 5 Minute Read Solutions to common challenges that manufacturers face when commercializing rare and orphan disease therapies.
Contracts & Pricing February 24, 2022 Branded Pharma Fee: Manufacturer Considerations 5 Minute Read And other regulatory updates on Line Extension guidance, the upcoming DUNS number transition, and emergency 340B flexibilities.
ICyte Platform February 15, 2022 Unifying IntegriChain’s Services & Support: Data Management 4 Minute Read President and COO Josh Halpern discusses the current and future capabilities of the integrated applications, analytics, and datastores within the ICyte Platform.
Gross-to-Net February 3, 2022 Forecasting for the Future 2 Minute Read How manufacturers can leverage successful returns and inventory pipeline reserve methodologies for long-term benefits.
Contracts & Pricing January 24, 2022 New Year, New Laws: Drug Price Reform, Coverage Gap, and 340B 4 Minute Read Potential and pending regulatory changes in 2022 including the current status of the Build Back Better Act and Part D Benefit Design.
